Valuation: Nihon Kohden Corporation

Capitalization 292B 1.84B 1.58B 1.47B 1.37B 2.55B 166B 2.75B 16.93B 6.65B 79.3B 6.89B 6.75B P/E ratio 2026 *
21.5x
P/E ratio 2027 * 17.2x
Enterprise value 275B 1.73B 1.49B 1.39B 1.29B 2.4B 156B 2.59B 15.93B 6.26B 74.64B 6.49B 6.35B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.11x
Free-Float
94.12%
Yield 2026 *
1.84%
Yield 2027 * 1.98%
More valuation ratios * Estimated data
Dynamic Chart
Jan. 05 Tranche Update on Nihon Kohden Corporation's Equity Buyback Plan announced on December 3, 2025. CI
Dec. 04 Nihon Kohden Brings Advanced EEG Technology Built on 70 Years of Innovation to Booth #725 at the American Epilepsy Society 2025 Annual Meeting CI
Dec. 03 Nihon Kohden Corporation announces an Equity Buyback for 3,800,000 shares, representing 2.33% for ¥5,000 million. CI
Dec. 02 Nihon Kohden Corporation authorizes a Buyback Plan. CI
Dec. 01 Nihon Kohden to Present Expert Sessions on Neonatal Ventilation and Lung Recruitability At AARC 2025 International Congress CI
Nov. 10 Nihon Kohden Corporation Provides Consolidated Earnings Guidance for Fiscal Year Ending March 31, 2026 CI
25-10-02 Nihon Kohden Launches AlarmSense to Reduce Alarm Fatigue for Clinical Teams CI
25-09-29 Nihon Kohden to End 38-Year Partnership with Abbott Medical Japan MT
25-09-29 Nihon Kohden Corp - Notice regarding implementation of career change support program and next career support program for employees RE
25-09-29 Nihon Kohden Corporation Announces Discontinuation of Providing Abbott Products in Japan CI
25-09-10 MINEBEA MITSUMI Inc. cancelled the acquisition of Shibaura Electronics Co.,Ltd. from a group of shareholders. CI
25-07-02 Nihon Kohden Corporation agreed to acquire remaining 28.60% stake in NeuroAdvanced Corp from NeuroNewCo, LP a fund managed by ArchiMed SAS for ¥7.4 billion. CI
25-05-21 Valueact Capital And Related Party Cut Stake In Nihon Kohden To 3.85% From 5.01%, Filing Shows RE
More news
1 day+1.32%
1 week+6.29%
Current month+7.01%
1 month+11.00%
3 months+4.62%
6 months+8.99%
Current year+7.01%
More quotes
1 week 1,694.5
Extreme 1694.5
1,815.5
1 month 1,607
Extreme 1607
1,815.5
Current year 1,683
Extreme 1683
1,815.5
1 year 1,494
Extreme 1494
2,465
3 years 1,494
Extreme 1494
2,465
5 years 1,381
Extreme 1381
2,465
10 years 1,112
Extreme 1112
2,465
More quotes
Manager TitleAgeSince
Chief Executive Officer 55 2024-03-31
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer 66 2024-03-31
Director TitleAgeSince
Director/Board Member 63 2017-05-31
Director/Board Member 66 2008-05-31
Director/Board Member 64 2021-06-24
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.32%+6.29%-10.71%+15.45% 1.83B
-2.30%-3.95%+7.32%+2.12% 231B
-2.65%-6.08%+3.16%+115.07% 203B
-2.91%-2.90%-4.23%-16.04% 169B
-2.62%-4.97%-1.78%+99.72% 142B
-0.49%+4.10%-7.88%-4.69% 61.2B
+0.31%-3.64%+16.37%+5.64% 48.17B
-1.85%-2.25%+1.64%-8.06% 41.95B
-1.74%-1.97%-0.40%+29.92% 39.58B
-1.67%+1.50%+9.84%+15.97% 37.56B
Average -1.43%+2.33%+1.33%+25.51% 97.53B
Weighted average by Cap. -2.21%+1.37%+2.13%+37.69%
See all sector performances

Financials

2026 *2027 *
Net sales 237B 1.49B 1.28B 1.19B 1.11B 2.07B 134B 2.23B 13.69B 5.38B 64.15B 5.57B 5.46B 239B 1.5B 1.29B 1.2B 1.12B 2.08B 135B 2.25B 13.81B 5.43B 64.69B 5.62B 5.51B
Net income 13.7B 86.09M 73.98M 68.99M 64.1M 120M 7.78B 129M 793M 312M 3.72B 323M 316M 17.04B 107M 92.01M 85.8M 79.73M 149M 9.67B 160M 986M 388M 4.62B 402M 393M
Net Debt -17.2B -108M -92.84M -86.57M -80.44M -150M -9.76B -162M -995M -391M -4.66B -405M -397M -27.78B -175M -150M -140M -130M -243M -15.76B -261M -1.61B -632M -7.53B -655M -641M
More financial data * Estimated data
Logo Nihon Kohden Corporation
NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.
Employees
6,114
More about the company
Date Price Change Volume
26-01-13 1,801.00 ¥ +1.32% 597,500
26-01-09 1,777.50 ¥ +0.03% 564,100
26-01-08 1,777.00 ¥ +2.72% 832,500
26-01-07 1,730.00 ¥ +1.08% 472,500
26-01-06 1,711.50 ¥ +1.00% 460,900

Delayed Quote Japan Exchange, January 13, 2026 at 01:30 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,801.00JPY
Average target price
2,108.57JPY
Spread / Average Target
+17.08%
Consensus

Quarterly revenue - Rate of surprise